The Apple Watch’s electrocardiogram (EKG) functionality violates one of the patents of AliveCor, a company much smaller than Apple. This is what Judge Cameron Elliot of the International Trade Commission (ITC) in the US initially decided.
The decision was officially released by authorities in the country and is announced by AliveCor, which sued Apple for patent infringement in April 2021. The small company accuses the Cupertino giant of violating the authorship of its products, as well as engaging in anti-competitive practices. – A joint lawsuit against Apple.
The judge’s decision is only the initial determination. The ITC will have until October 26, 2022, to give a final opinion on the process, which could result in not only a fine for Apple but also a ban on sale of certain models of the Watch in the US.
“Today’s decision is a strong validation of our IP (intellectual property) and underlines that patents are important and that even an influential company like Apple cannot infringe upon them to hinder innovation,” said Priya Abani, CEO of AliveCor. Apple did not comment on the decision.
)
-
Rear camera: 12 MP (f/1.6, 26mm, 1.7µm) + 12 MP (f/2.2, 65mm, 1/3.4″, 1.0µm) + 12 MP (f/2.4, 120˚, 13mm, 1/3.6″) + TOF 3-dimensional
-
Front camera: 12 MP (f/2.2, 23mm, 1/3.6″) + SL 3D
-
Video: 4K@24/30/60fps, 1080p@30/60/120/240fps
Source: Tec Mundo
